Trademarkia Logo

United Kingdom

£
Registered

on 5 Mar 2020

Last Applicant/ Owned by

Celgene Corporation

86 Morris Avenue, Summit, New Jersey 07901, United States of America

, ,

Serial Number

UK00003472712 filed on 5th Mar 2020

Registration Number

UK00003472712 registered on
9th Aug 2020

Correspondent Information

Sipara Limited

Rochester House, Eynsham Road, Farmoor

Oxford,

OX2 9NH

REBLOZYL

pharmaceutical preparations for use in the treatment of anemia, beta thalassemia, myelodsplatic syndromes, autoinflammatory disease, autoimmune diseas Read More

Classification Information


Class [5]
Pharmaceutical Products


Pharmaceutical preparations for use in the treatment of anemia, beta thalassemia, myelodsplatic syndromes, autoinflammatory disease, autoimmune disease, blood disease, cancer, arthritis, musculoskeletal and skin diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system.

Mark Details


Serial Number

UK00003472712

Mark Type

Figurative

Kind of mark

Individual